Financials · mywealthgrid

Standalone figures · ₹ crore

₹ Cr	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	2,233	1,365	2,148	2,330	2,636	2,251	2,009	2,395	1,539	2,360	2,147	2,435
COGS	894	695	765	794	834	785	786	718	656	871	833	819
Gross profit	1,339	670	1,383	1,536	1,802	1,466	1,223	1,677	882	1,489	1,313	1,616
	868	854	886	904	1,023	972	883	949	1,060	993	1,282	1,003
	471	-184	497	631	779	494	341	728	-178	496	32	613
OPM %	21.1%	-13.5%	23.2%	27.1%	29.5%	21.9%	17%	30.4%	-11.6%	21%	1.5%	25.2%
Depreciation	50	51	52	53	55	55	56	58	59	59	60	62
Interest	58	74	83	15	12	8	13	15	23	22	18	23
	27	234	5,933	56	83	129	-91	-254	-646	-68	-61	338
Profit before tax	389	-76	6,295	618	795	559	181	401	-906	347	-107	866
Tax	87	-55	1,681	165	200	146	33	71	-167	64	-33	130
Tax %	22.4%	-73%	26.7%	26.6%	25.2%	26%	18.4%	17.7%	-18.5%	18.6%	-31.2%	15.1%
	302	-20	4,614	454	595	414	148	330	-739	282	-74	736
PAT margin %	13.5%	-1.5%	214.8%	19.5%	22.6%	18.4%	7.4%	13.8%	-48%	12%	-3.4%	30.2%
EPS (₹)	10.7	-0.7	163.5	16.1	21.1	14.7	5.2	11.7	-26.2	10	-2.6	26.1
Results filing	—	—	—	—	—	—	—	Results filing for Jun 2025	—	—	—	—

vs same quarter last year	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue YoY %	+1.1%	-36.8%	+10.8%	+8.6%	+18%	+64.9%	-6.5%	+2.8%

Glenmark Pharmaceuticals Limited